Note 3 - Selected Balance Sheet Data (Tables)

6 Months Ended

Dec. 31, 2021

Notes Tables

Schedule of Inventory, Current [Table Text Block]

	December 31,		June 30,
	2021		2021
Raw materials	$	61,624	$	55,096
Finished goods(1)		65,620		67,108
Inventories, net	$	127,244	$	122,204

Property, Plant and Equipment [Table Text Block]

	December 31,			June 30,
	2021			2021
Land	$	8,587		$	8,612
Buildings and improvements		225,501			190,661
Machinery and equipment		161,431			149,410
Construction in progress		17,386			49,073
Property and equipment, cost		412,905			397,756
Accumulated depreciation and amortization		(201,091	)		(189,849	)
Property and equipment, net	$	211,814		$	207,907

Schedule of Intangible Assets and Goodwill [Table Text Block]

	December 31,			June 30,
	2021			2021
Developed technology	$	544,388		$	552,160
Trade names		147,327			147,640
Customer relationships		228,419			232,493
Patents		3,116			2,926
Other intangibles		6,309			6,316
Definite-lived intangible assets		929,559			941,535
Accumulated amortization		(382,912	)		(348,267	)
Definite-lived intangibles assets, net		546,647			593,268
In process research and development		22,700			22,700
Total intangible assets, net	$	569,347		$	615,968

Schedule of Finite-Lived Intangible Assets [Table Text Block]

Beginning balance	$	615,968
Acquisitions		-
Other additions		171
Amortization expense		(37,258	)
Currency translation		(971	)
Eminence impairment (1)		(8,563	)
Ending balance	$	569,347

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]

2022 remainder	$	36,927
2023		71,669
2024		68,818
2025		65,579
2026		61,819
Thereafter		241,835
Total	$	546,647

Schedule of Goodwill [Table Text Block]

	Protein Sciences			Diagnostics and Genomics			Total
Beginning balance	$	392,717		$	450,350		$	843,067
Acquisitions		-			-			-
Eminence impairment		(8,275	)		-			(8,275	)
Currency translation		(2,610	)		(126	)		(2,736	)
Ending balance	$	381,832		$	450,224		$	832,056